NOT-CA-01-011: IV MAGNESIUM FOR TREATING ACUTE, SEVERE ASTHMA EXACERBATIONS (MASA)

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®



IV MAGNESIUM FOR TREATING ACUTE, SEVERE ASTHMA EXACERBATIONS (MASA)

Release Date:  April 10, 2001

NOTICE:  NOT-CA-01-011

RFP No. N01-AT-11022-64
RFP RELEASE DATE:  04/12/2001
RESPONSES DUE:     07/11/2001

National Cancer Institute

NATIONAL CENTER FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE
DESCRIPTION:  TO ELECTRONIC RFP ANNOUNCEMENT - POTENTIAL OFFERORS WILL 
BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND 
ANY AMENDMENTS.  The National Institutes of Health (NIH), The National 
Center for Complementary and Alternative Medicine seeks a Contractor to 
conduct a randomized, double blind, placebo-controlled clinical trial 
to determine the impact of adjuvant intravenous (IV) magnesium sulfate 
treatment on hospitalization rates and serial spirometric lung function 
for patients who present to the emergency department (ED) with severe, 
acute asthma and do not respond to standard therapy.  In a randomly 
selected sample of the population, baseline and post treatment levels 
of intracellular magnesium should be assessed as they may be a 
significant determinant of response.   The North American Industry 
Classification System (NAICS) code is 541710.  Request for Proposals 
(RFP) No. N01-AT-11022-64 will be AVAILABLE ELECTRONICALLY and may be 
downloaded at URL http://rcb.nci.nih.gov/appl/rfp/rfps_published.jsp on 
or about April 12, 2001.  This solicitation will be issued in 
electronic format only.  Proposals will be due on or about July 11.  
The exact proposal receipt date will be specified in the solicitation.  
OFFERORS ARE RESPONSIBLE FOR ROUTINELY CHECKING THIS WEBSITE FOR ANY 
POSSIBLE SOLICITATION AMENDMENTS THAT MAY BE ISSUED.  NO INDIVIDUAL 
NOTIFICATION OF ANY AMENDMENTS WILL BE PROVIDED.  This advertisement 
does not commit the Government to award a contract. All responsible 
sources may submit a proposal, which will be considered by the agency.

Inquiries may be directed to:

James D. Carder, Contract Specialist
Research Contracts Branch
National Cancer Institute
Phone:  (301)435-3776
Fax:  (301)480-0241
[email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices